35836711000001108: Bicalutamide 150mg tablets (Crescent Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\UK product\Virtual medicinal product\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Crescent Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

110014101000001113 Bicalutamide 150mg tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

110014201000001118 Bicalutamide 150mg tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Is a	Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has basis of strength substance	Bicalutamide	true	Inferred relationship	Existential restriction modifier	1
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has presentation strength numerator value	150	false	Inferred relationship	Existential restriction modifier	1
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has precise active ingredient	Bicalutamide	true	Inferred relationship	Existential restriction modifier	1
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has unit of presentation	Tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has specific active ingredient	Bicalutamide	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bicalutamide 150mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Bicalutamide 150mg tablets (Crescent Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
110014101000001113	Bicalutamide 150mg tablets (Crescent Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
110014201000001118	Bicalutamide 150mg tablets (Crescent Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module